https://www.selleckchem.com/pr....oducts/liproxstatin-
37mIU/mL, P 0.007). More patients with TSH 1mIU/L developed thyroid dysfunction as compared to subjects with TSH ≥1 mIU/L (P .022). There was no significant difference in the incidence of thyroid dysfunction on the basis of gender, race, smoking status, TPO Ab positivity and number of nodules at diagnosis. We recommend re-examining the current practice and clinical utility of frequent TSH monitoring in all patients with thyroid nodules, particularly if initial TSH level is ≥1mIU/L. We recommend re-examining the current practi
Like
Comment
Share
